Author:
Wang T.,Yang L.,Jiang J.,Liu Y.,Fan Z.,Zhong C.,He C.
Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism
Reference101 articles.
1. (2001) NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy, March 7-29, 2000: highlights of the conference. South Med J 94(6):569–73
2. Tanaka Y, Ohira T (2018) Mechanisms and therapeutic targets for bone damage in rheumatoid arthritis, in particular the RANK-RANKL system. Curr Opin Pharmacol 40:110–119
3. Minisola S, Scillitani A, Romagnoli E (2006) Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis. N Engl J Med 355(20):2156–2157 author reply 7
4. Jacobs JW, de Nijs RN, Lems WF (2007) Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: relations of change in bone mineral density, bone markers, and calcium homeostasis. J Rheumatol 34(5):1051–1057
5. Canalis E, Mazziotti G, Giustina A (2007) Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int 18(10):1319–1328
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献